Resistance Training With Blood Flow Restriction in Hemophilia
HemoBFR
The Acute and Chronic Impact of Blood Flow Restriction Resistance Training on Physical and Neuromuscular Function, Pain, and Quality of Life in Patients With Moderate/Severe Hemophilia
1 other identifier
interventional
20
1 country
1
Brief Summary
The main objectives of this study are to evaluate safety and chronic effects of a low-load resistance exercise intervention (elbow flexions and extensions, and knee extensions) with blood flow restriction in people with hemophilia on quality of life, pain, and on physical and neuromuscular function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2022
CompletedFirst Posted
Study publicly available on registry
October 5, 2022
CompletedStudy Start
First participant enrolled
January 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedFebruary 3, 2026
January 1, 2026
2 years
September 29, 2022
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
HDsEMG
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
Baseline and week 8.
Hand-held dynamometry (isometric elbow flexion/extension, knee extension)
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
Baseline and week 8.
Muscle ultrasound (muscle mass, assessment of possible bleedings)
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
Baseline and week 8.
Digital goniometry for active elbow and knee ROM
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
Baseline and week 8.
Secondary Outcomes (5)
Self-reported pain intensity (Visual Analogue Scale (VAS) Scale 0-10)
Baseline and week 8.
Pressure pain thresholds (digital algometry)
Baseline and week 8.
Haemophilia Activities List (HAL) questionnaire
Baseline and week 8.
A36 haemophilia quality of life (Hemofilia-QoL) questionnaire
Baseline and week 8.
Patient Global Impression of Change Scale (PGICS)
Baseline and week 8.
Study Arms (2)
Control
ACTIVE COMPARATORThe training program for the control group consists of a telerehabilitation with traditional moderate-to-high load (60%-80% 1RM) exercises (the same as the intervention group sans BFR), utilizing elastic bands. This program for the control group will be conducted in an in-home real-time audio and video style and supervised by a physiotherapist.
BFRT
EXPERIMENTALThe BFR training program for the intervention group consists of elbow flexion and extension, and knee extension exercises performed with low load (elastic bands; equivalent to 30% 1RM) and concurrent BFR (upper limb 50% AOP; lower limb 60% AOP). Subjects will perform 4 sets (30, 15, 15 and 15 reps) of each exercise with 30 s rest between sets and 5-minute rest between exercises.
Interventions
Eligibility Criteria
You may qualify if:
- diagnosis of hemophilia A or B and undergoing prophylaxis;
- willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations;
- approval by their hematologist to participate in the exercise program;
- age between 18 and 60 years;
- informed consent signed.
You may not qualify if:
- the inability to attend exercise sessions at least twice a week for 8 consecutive weeks;
- non adherence to instruction on proper exercise technique;
- surgical procedures performed 6 weeks prior to or during the exercise program; - participation in any other form of exercise, not previously done, during the study;
- changes in medication during the study;
- a major bleeding episode that posed a risk or prevented exercise;
- another hemostatic defect;
- need for major surgery;
- withdrawal of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Facultat de Fisioteràpia
Valencia, Valencia, 46010, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sofía Pérez Alenda
University of Valencia
- STUDY CHAIR
Joaquín Calatayud
University of Valencia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dean of Faculty of Physiotherapy
Study Record Dates
First Submitted
September 29, 2022
First Posted
October 5, 2022
Study Start
January 15, 2024
Primary Completion
January 30, 2026
Study Completion
January 30, 2026
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share